January 11, 2013
Hiroshi Mikami, Executive Member of the Board of Trustees, JMA With pharmaceutical manufacturers scheduled to begin disclosing information on payments to healthcare professionals based on new transparency guidelines that will go into effect this year, the Japan Medical Association (JMA)...read more